| IXC Stock | | | 0.07 0.01 7.46% |
Invex Therapeutics financial indicator trend analysis is infinitely more than just investigating Invex Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Invex Therapeutics is a good investment. Please check the relationship between Invex Therapeutics Common Stock Total Equity and its Cash accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Common Stock Total Equity vs Cash
Common Stock Total Equity vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Invex Therapeutics Common Stock Total Equity account and
Cash. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Invex Therapeutics' Common Stock Total Equity and Cash is 0.45. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Cash in the same time period over historical financial statements of Invex Therapeutics, assuming nothing else is changed. The correlation between historical values of Invex Therapeutics' Common Stock Total Equity and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of Invex Therapeutics are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Common Stock Total Equity i.e., Invex Therapeutics' Common Stock Total Equity and Cash go up and down completely randomly.
Correlation Coefficient | 0.45 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.
Cash
Cash refers to the most liquid asset of Invex Therapeutics, which is listed under current asset account on Invex Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Invex Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Invex Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Invex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Invex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Issuance Of Capital Stock is likely to gain to about 10
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 1.1
M in 2024.
Invex Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Invex Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Invex Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Invex Stock Analysis
When running Invex Therapeutics' price analysis, check to
measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.